4-122827273-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_ModerateBP6_ModerateBP7BS2
The NM_001361665.2(FGF2):c.99C>T(p.Tyr33=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00048 in 1,612,904 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00024 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00050 ( 3 hom. )
Consequence
FGF2
NM_001361665.2 synonymous
NM_001361665.2 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 3.26
Genes affected
FGF2 (HGNC:3676): (fibroblast growth factor 2) The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members bind heparin and possess broad mitogenic and angiogenic activities. This protein has been implicated in diverse biological processes, such as limb and nervous system development, wound healing, and tumor growth. The mRNA for this gene contains multiple polyadenylation sites, and is alternatively translated from non-AUG (CUG) and AUG initiation codons, resulting in five different isoforms with distinct properties. The CUG-initiated isoforms are localized in the nucleus and are responsible for the intracrine effect, whereas, the AUG-initiated form is mostly cytosolic and is responsible for the paracrine and autocrine effects of this FGF. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.45).
BP6
Variant 4-122827273-C-T is Benign according to our data. Variant chr4-122827273-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 740852.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=3.26 with no splicing effect.
BS2
High AC in GnomAd4 at 37 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FGF2 | NM_001361665.2 | c.99C>T | p.Tyr33= | synonymous_variant | 1/3 | ENST00000644866.2 | NP_001348594.1 | |
FGF2 | NM_002006.6 | c.498C>T | p.Tyr166= | synonymous_variant | 1/3 | NP_001997.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGF2 | ENST00000644866.2 | c.99C>T | p.Tyr33= | synonymous_variant | 1/3 | NM_001361665.2 | ENSP00000494222 | P1 | ||
FGF2 | ENST00000264498.9 | c.498C>T | p.Tyr166= | synonymous_variant | 1/3 | 1 | ENSP00000264498 | |||
FGF2 | ENST00000608478.1 | c.99C>T | p.Tyr33= | synonymous_variant | 1/3 | 1 | ENSP00000477134 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152110Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
37
AN:
152110
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000291 AC: 71AN: 244150Hom.: 0 AF XY: 0.000269 AC XY: 36AN XY: 134046
GnomAD3 exomes
AF:
AC:
71
AN:
244150
Hom.:
AF XY:
AC XY:
36
AN XY:
134046
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000505 AC: 737AN: 1460676Hom.: 3 Cov.: 33 AF XY: 0.000497 AC XY: 361AN XY: 726670
GnomAD4 exome
AF:
AC:
737
AN:
1460676
Hom.:
Cov.:
33
AF XY:
AC XY:
361
AN XY:
726670
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000243 AC: 37AN: 152228Hom.: 0 Cov.: 31 AF XY: 0.000269 AC XY: 20AN XY: 74444
GnomAD4 genome
AF:
AC:
37
AN:
152228
Hom.:
Cov.:
31
AF XY:
AC XY:
20
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 25, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at